Richard Owusu Ansah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard Owusu Ansah has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Stephen Twumasi
Department of Medical Diagnostics Kwame Nkrumah University of Science and Technology Kumasi Ghana
6 shared publications - Allwell Adofo Ayirebi
Department of Medical Diagnostics, Faculty of Allied Health Sciences, College of Health Sciences Kwame Nkrumah University of Science and Technology Kumasi Ghana
5 shared publications Angela Opoku
Laboratrory Unit Komfo Anokye Teaching Hospital Kumasi Ghana
4 shared publications- Daniel Nii Martey Antonio
Department of Molecular Medicine, School of Medicine and Dentistry Kwame Nkrumah University of Science and Technology Kumasi Ghana
3 shared publications - Benedict Sackey
Department of Medical Diagnostics, Faculty of Allied Health Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
2 shared publications Enoch Odame Anto
Department of Medical Diagnostics, Faculty of Allied Health Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
2 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (8)
Acute and Chronic Leukemia in Sub‐Saharan Africa: A Systematic Review
Background: The four primary subgroups of leukemia include chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). Very little is known about the regional variation of leukemia and subtypes in sub‐Saharan Africa (SSA). Aims: This systematic review focused on the prevalent cases reported in sub‐Saharan Africa, throwing more emphasis on treatment outcomes, follow up time and survival rates. Methods: A systematic review of studies on acute and chronic leukemia in sub‐Saharan Africa (SSA) was conducted using articles retrieved from PubMed, Scopus, Google Scholar, Embase and African‐specific databases such as African Journals Online (AJOL), covering publications from 1975 to July 15, 2025. Results: A total of 94 studies were subjected to initial screening from study titles. Thirty‐two (32) articles that met the inclusion criteria were selected for inclusion in this systematic review. Out of 2537 leukemia cases reported in the 32 studies, 1644 (64.80%) were acute and 893 (35.20%) were chronic. AML accounted for 947 (37.33%), 450 (17.74%) were ALL, 720 (28.38%) were CML, 173 (6.82%) were CLL, 2 (0.08%) were acute undifferentiated leukemia, 1 (0.04%) was mixed phenotype acute leukemia and 244 (9.62%) unclassified leukemias. Survival rates ranged from 2 weeks to 5 years. Fifty‐nine patients were lost to follow up and follow up time ranged from 11 months to 7 years. 273 (10.76%) leukemia related deaths were reported. Conclusion: This review found that acute leukemias were more prevalent than chronic leukemias, with AML emerging as the most frequently reported subtype. Survival durations ranged from a few weeks to five years; however, overall outcomes remained poor, characterized by high mortality rates and substantial loss to follow‐up. These findings underscore the urgent need for improved diagnostic capacity, standardized treatment protocols, and strengthened patient monitoring and follow‐up systems to enhance leukemia care and outcomes.
- 31 July 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (8)
Open AccessAcute and Chronic Leukemia in Sub‐Saharan Africa: A Systematic Review
Background: The four primary subgroups of leukemia include chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). Very little is known about the regional variation of leukemia and subtypes in sub‐Saharan Africa (SSA). Aims: This systematic review focused on the prevalent cases reported in sub‐Saharan Africa, throwing more emphasis on treatment outcomes, follow up time and survival rates. Methods: A systematic review of studies on acute and chronic leukemia in sub‐Saharan Africa (SSA) was conducted using articles retrieved from PubMed, Scopus, Google Scholar, Embase and African‐specific databases such as African Journals Online (AJOL), covering publications from 1975 to July 15, 2025. Results: A total of 94 studies were subjected to initial screening from study titles. Thirty‐two (32) articles that met the inclusion criteria were selected for inclusion in this systematic review. Out of 2537 leukemia cases reported in the 32 studies, 1644 (64.80%) were acute and 893 (35.20%) were chronic. AML accounted for 947 (37.33%), 450 (17.74%) were ALL, 720 (28.38%) were CML, 173 (6.82%) were CLL, 2 (0.08%) were acute undifferentiated leukemia, 1 (0.04%) was mixed phenotype acute leukemia and 244 (9.62%) unclassified leukemias. Survival rates ranged from 2 weeks to 5 years. Fifty‐nine patients were lost to follow up and follow up time ranged from 11 months to 7 years. 273 (10.76%) leukemia related deaths were reported. Conclusion: This review found that acute leukemias were more prevalent than chronic leukemias, with AML emerging as the most frequently reported subtype. Survival durations ranged from a few weeks to five years; however, overall outcomes remained poor, characterized by high mortality rates and substantial loss to follow‐up. These findings underscore the urgent need for improved diagnostic capacity, standardized treatment protocols, and strengthened patient monitoring and follow‐up systems to enhance leukemia care and outcomes.
- Open Access
- 25 March 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1)
A narrative review of lessons from Ghana’s COVID-19 response to inform future pandemic preparedness
- 25 March 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1)
Open AccessA narrative review of lessons from Ghana’s COVID-19 response to inform future pandemic preparedness
- 3 June 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (4) , e70043
Human Metapneumovirus: A Review of Its Epidemiology, Clinical Features, Public Health Implications and Treatment Options
Importance of the field: Significant complications arise from Human Metapneumovirus (hMPV), especially in susceptible groups. hMPV infection is highly prevalent in children, accounting for about 10% hospitalizations for acute respiratory infections, often resulting in pneumonia and bronchiolitis. Hence, there is need for new knowledge to understand the structure, the clinical features, diagnostics, treatment options and the complications of the hMPV. Areas covered in this review: This review covered the epidemiology, clinical features, diagnostics, treatment options and public health implications of hMPV. What the reader will gain: Knowledge of the clinical manifestation, implications and the methods currently available for diagnosing and treating human metapneumovirus. Take home message: hMPV is a major cause of acute respiratory tract infections (ARTIs), affecting children, elderly, and immunocompromised individuals globally. Symptoms include rhinorrhoea, nasal congestion, cough, fever, with symptoms ranging from mild to severe. Laboratory findings include leucocytosis, leucopenia, neutrophilia, lymphopenia, and elevated inflammatory markers. In adults, they often mimic influenza and potentially exacerbate chronic conditions like chronic obstructive pulmonary disease (COPD) or asthma. Hospitalisation is often required for infants with significant respiratory distress. The genetic variability and antigenic diversity of the virus complicate vaccine design. Hence, advanced research tailored towards producing effective vaccines treatments for the hMPV viral disease is relevant to contain the complications associated with the virus.
- 3 June 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (4) , e70043
Human Metapneumovirus: A Review of Its Epidemiology, Clinical Features, Public Health Implications and Treatment Options
Importance of the field: Significant complications arise from Human Metapneumovirus (hMPV), especially in susceptible groups. hMPV infection is highly prevalent in children, accounting for about 10% hospitalizations for acute respiratory infections, often resulting in pneumonia and bronchiolitis. Hence, there is need for new knowledge to understand the structure, the clinical features, diagnostics, treatment options and the complications of the hMPV. Areas covered in this review: This review covered the epidemiology, clinical features, diagnostics, treatment options and public health implications of hMPV. What the reader will gain: Knowledge of the clinical manifestation, implications and the methods currently available for diagnosing and treating human metapneumovirus. Take home message: hMPV is a major cause of acute respiratory tract infections (ARTIs), affecting children, elderly, and immunocompromised individuals globally. Symptoms include rhinorrhoea, nasal congestion, cough, fever, with symptoms ranging from mild to severe. Laboratory findings include leucocytosis, leucopenia, neutrophilia, lymphopenia, and elevated inflammatory markers. In adults, they often mimic influenza and potentially exacerbate chronic conditions like chronic obstructive pulmonary disease (COPD) or asthma. Hospitalisation is often required for infants with significant respiratory distress. The genetic variability and antigenic diversity of the virus complicate vaccine design. Hence, advanced research tailored towards producing effective vaccines treatments for the hMPV viral disease is relevant to contain the complications associated with the virus.
- Open Access
- 30 May 2025
- Published by Springer Nature in Research Square
Bridging the knowledge Gap: A Systematic Review of Acute and Chronic Leukemia Research in Sub-Saharan Africa – Progress Achieved and Future Directions
Background: The four primary subgroups of leukemia include chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphoblastic leukemia (CLL). Very little is known about the regional variation of leukemia and subtypes in sub-Saharan Africa (SSA). A lot of cases go undiagnosed and others diagnosed at latter stages. This systematic review focused on the prevalent cases reported in sub-Saharan Africa, throwing more emphasis on treatment outcomes, follow up time and survival rates. Methods: A systematic review of papers published on acute and chronic leukemia in SSA were retrieved from PubMed, Scopus, Google Scholar, and African-specific databases (e.g., AJOL - African Journals Online), from initiation date up until inclusion on the March 31, 2025. Results: A total of 79 studies were subjected to initial screening from study titles. Seventeen (17) articles that met the inclusion criteria were selected for inclusion in the systematic review. Out of 932 leukemia cases reported in the 17 studies, 496(53.2%) were acute and 436(46.8%) were chronic. 172(18.5%) were AML, 262(28.1%) were ALL, 421(45.2%) were CML, 15(1.6%) were CLL, 2(0.2%) were acute undifferentiated leukemia, 1(0.1%) was mixed phenotype acute leukemia and 59(6.3%) unknown acute leukemias. Survival rates ranged from 2 weeks to 3 years. Fifty-eight patients were lost to follow up, follow up time ranged from 11months to 7 years and 165(17.7%) deaths were reported Conclusion: Leukemia is prevalent in sub-Saharan Africa but diagnostic and treatment challenges contribute to the low prevalence reported in the region. We therefore recommended enhancing laboratory and diagnostic facilities as well as providing access to contemporary diagnostic tools such as molecular diagnostics, cytogenetic testing, and flow cytometers; and implementing continuous professional development programs to train healthcare providers. Systematic Review Registration: The protocol for the study has been registered in PROSPERO with the following ID number: CRD420251025330.
- 30 May 2025
- Published by Springer Nature in Research Square
Open AccessBridging the knowledge Gap: A Systematic Review of Acute and Chronic Leukemia Research in Sub-Saharan Africa – Progress Achieved and Future Directions
Background: The four primary subgroups of leukemia include chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphoblastic leukemia (CLL). Very little is known about the regional variation of leukemia and subtypes in sub-Saharan Africa (SSA). A lot of cases go undiagnosed and others diagnosed at latter stages. This systematic review focused on the prevalent cases reported in sub-Saharan Africa, throwing more emphasis on treatment outcomes, follow up time and survival rates. Methods: A systematic review of papers published on acute and chronic leukemia in SSA were retrieved from PubMed, Scopus, Google Scholar, and African-specific databases (e.g., AJOL - African Journals Online), from initiation date up until inclusion on the March 31, 2025. Results: A total of 79 studies were subjected to initial screening from study titles. Seventeen (17) articles that met the inclusion criteria were selected for inclusion in the systematic review. Out of 932 leukemia cases reported in the 17 studies, 496(53.2%) were acute and 436(46.8%) were chronic. 172(18.5%) were AML, 262(28.1%) were ALL, 421(45.2%) were CML, 15(1.6%) were CLL, 2(0.2%) were acute undifferentiated leukemia, 1(0.1%) was mixed phenotype acute leukemia and 59(6.3%) unknown acute leukemias. Survival rates ranged from 2 weeks to 3 years. Fifty-eight patients were lost to follow up, follow up time ranged from 11months to 7 years and 165(17.7%) deaths were reported Conclusion: Leukemia is prevalent in sub-Saharan Africa but diagnostic and treatment challenges contribute to the low prevalence reported in the region. We therefore recommended enhancing laboratory and diagnostic facilities as well as providing access to contemporary diagnostic tools such as molecular diagnostics, cytogenetic testing, and flow cytometers; and implementing continuous professional development programs to train healthcare providers. Systematic Review Registration: The protocol for the study has been registered in PROSPERO with the following ID number: CRD420251025330.
- Open Access
- 23 December 2024
- Published by Springer Nature in Research Square
Haemato-urological profile and asymptomatic urinary tract infection in Ghanaian steady-state sickle cell disease patients.
Background: Due to the reduction in immunity caused by auto-splenectomy and the consequent opsonic antibody shortage, patients with SCD are more susceptible to encapsulated organism infections, especially asymptomatic urinary tract infection (ASM-UTI). This study investigated the prevalence of asymptomatic urinary tract infection and compared urine and haematology parameters among SCD patients in Ghana to their healthy counterparts. Methods: In this study, 104 SCD participants and 80 non-SCD subjects were recruited. Participants' information was thoroughly documented using a well-structured questionnaire and patient case records. To evaluate the prevalence of asymptomatic urinary tract infection, a clean catch early morning urine was collected from each participant and cultured on Cystine-Lactose-Electrolyte Deficient (CLED). Also, venous blood was collected for the haematological profile of the study participants. Findings: Prevalence of ASM-UTI among SCD participants and non-SCD individuals were 22(21.2%) and 18(22.5%) respectively. S. aureus 15 (8.2%) accounted for the majority of the organisms isolated with the larger proportion 9(60.0%) being isolated from the SCD patients. This study found a statistical difference between SCD with ASM-UTI, without ASM-UTI, and non-SCD with respect to urine appearance (p=0.047), proteinuria (p=0.024), leucocyte (p<0.0001). Significantly high total WBC (p<0.0001), low platelets (p<0.0001), and low haemoglobin (p<0.0001) in SCD with ASM-UTI compared to non-SCD with ASM-UTI were also observed. Major risk factors associated with ASM-UTI includes a cloudy urine appearance (8.11, p<0.042), a positive (+1) and positive (+2) urine leucocytes and positive (+1) urine bilirubin with a significantly increased odd (7.65, p=0.001), (9.50, p=0.001) and (3.39, p=0.019) respectively of having ASM-UTI in SCD compared to having a clear urine appearance, a negative urine leucocyte, and a negative urine bilirubin. Conclusion: This study has shown ASM-UTI to be common in adult SCD participants with higher rate in females. This study also showed that ASM-UTI can exist alongside other clinical states such as anaemia, microalbuminuria, haematuria and proteinuria which are characteristics of kidney disease which can trigger crises in SCD participants.
- 23 December 2024
- Published by Springer Nature in Research Square
Open AccessHaemato-urological profile and asymptomatic urinary tract infection in Ghanaian steady-state sickle cell disease patients.
Background: Due to the reduction in immunity caused by auto-splenectomy and the consequent opsonic antibody shortage, patients with SCD are more susceptible to encapsulated organism infections, especially asymptomatic urinary tract infection (ASM-UTI). This study investigated the prevalence of asymptomatic urinary tract infection and compared urine and haematology parameters among SCD patients in Ghana to their healthy counterparts. Methods: In this study, 104 SCD participants and 80 non-SCD subjects were recruited. Participants' information was thoroughly documented using a well-structured questionnaire and patient case records. To evaluate the prevalence of asymptomatic urinary tract infection, a clean catch early morning urine was collected from each participant and cultured on Cystine-Lactose-Electrolyte Deficient (CLED). Also, venous blood was collected for the haematological profile of the study participants. Findings: Prevalence of ASM-UTI among SCD participants and non-SCD individuals were 22(21.2%) and 18(22.5%) respectively. S. aureus 15 (8.2%) accounted for the majority of the organisms isolated with the larger proportion 9(60.0%) being isolated from the SCD patients. This study found a statistical difference between SCD with ASM-UTI, without ASM-UTI, and non-SCD with respect to urine appearance (p=0.047), proteinuria (p=0.024), leucocyte (p<0.0001). Significantly high total WBC (p<0.0001), low platelets (p<0.0001), and low haemoglobin (p<0.0001) in SCD with ASM-UTI compared to non-SCD with ASM-UTI were also observed. Major risk factors associated with ASM-UTI includes a cloudy urine appearance (8.11, p<0.042), a positive (+1) and positive (+2) urine leucocytes and positive (+1) urine bilirubin with a significantly increased odd (7.65, p=0.001), (9.50, p=0.001) and (3.39, p=0.019) respectively of having ASM-UTI in SCD compared to having a clear urine appearance, a negative urine leucocyte, and a negative urine bilirubin. Conclusion: This study has shown ASM-UTI to be common in adult SCD participants with higher rate in females. This study also showed that ASM-UTI can exist alongside other clinical states such as anaemia, microalbuminuria, haematuria and proteinuria which are characteristics of kidney disease which can trigger crises in SCD participants.
- Open Access
Neutrophil gelatinase-associated lipocalin and Fibrinogen-to-albumin ratio are indicators of nephropathy in adult steady state sickle cell disease patients: A multicenter case-control study in Ghana
Background: Progressive renal failure is one of the main complications in sickle cell disease. Neutrophil Gelatinase-Associated Lipocalin (NGAL) is present in gelatinase/tertiary granules of neutrophils and it is a relatively newly recognized marker of nephropathy. Fibrinogen increases and albumin decreases in inflammatoy conditions like SCD. This study investigated the diagnostic roles of NGAL and fibrinogen-to-albumin ratio in steady state adult sickle cell disease patients. Methods: In this study, 104 sickle cell disease participants and 51 healthy subjects were analysed. Participants’ information was thoroughly documented using a structured questionnaire and patient case records. To evaluate the hematobiochemical parameters, 5ml of venous blood was drawn from each participant and a clean catch of mid-stream urine was collected from each participant. Subjects with sickle cell disease were further classified as SCD nephropathy and SCD non- nephropathy subjects based on reduced estimated Glomerular Filtration Rate (eGFR) and microalbuminuria. Results: Prevalence of nephropathy was 32.7% among adult steady state SCD patients. Significant high levels of Urine Albumin-to-Creatinine Ratio (UACR), NGAL and fibrinogen-to-albumin ratio (FAR) were seen in SCD patients with nephropathy compared to those without nephropathy ( p p p p p p p p p =0.048 and AUC=0.531, p =0.647 respectively. However, FAR could not be used as a predictive marker since it had non-significant poor performance (AUC=0.462, p =0.536). Conclusion: NGAL as independent marker, is an early predictor of kidney disease as compared to urea and creatinine. Fibrinogen-to-albumin ratio can be used to track nephropathy treatment in steady state sickle cell disease patients since it is elevated in those with sickle cell nephropathy compared to healthy individuals. These two markers can be added to the available array of test in the management of nephropathy among steady SCD patients.
Open AccessNeutrophil gelatinase-associated lipocalin and Fibrinogen-to-albumin ratio are indicators of nephropathy in adult steady state sickle cell disease patients: A multicenter case-control study in Ghana
Background: Progressive renal failure is one of the main complications in sickle cell disease. Neutrophil Gelatinase-Associated Lipocalin (NGAL) is present in gelatinase/tertiary granules of neutrophils and it is a relatively newly recognized marker of nephropathy. Fibrinogen increases and albumin decreases in inflammatoy conditions like SCD. This study investigated the diagnostic roles of NGAL and fibrinogen-to-albumin ratio in steady state adult sickle cell disease patients. Methods: In this study, 104 sickle cell disease participants and 51 healthy subjects were analysed. Participants’ information was thoroughly documented using a structured questionnaire and patient case records. To evaluate the hematobiochemical parameters, 5ml of venous blood was drawn from each participant and a clean catch of mid-stream urine was collected from each participant. Subjects with sickle cell disease were further classified as SCD nephropathy and SCD non- nephropathy subjects based on reduced estimated Glomerular Filtration Rate (eGFR) and microalbuminuria. Results: Prevalence of nephropathy was 32.7% among adult steady state SCD patients. Significant high levels of Urine Albumin-to-Creatinine Ratio (UACR), NGAL and fibrinogen-to-albumin ratio (FAR) were seen in SCD patients with nephropathy compared to those without nephropathy ( p p p p p p p p p =0.048 and AUC=0.531, p =0.647 respectively. However, FAR could not be used as a predictive marker since it had non-significant poor performance (AUC=0.462, p =0.536). Conclusion: NGAL as independent marker, is an early predictor of kidney disease as compared to urea and creatinine. Fibrinogen-to-albumin ratio can be used to track nephropathy treatment in steady state sickle cell disease patients since it is elevated in those with sickle cell nephropathy compared to healthy individuals. These two markers can be added to the available array of test in the management of nephropathy among steady SCD patients.
- Open Access
- 31 January 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-11
Knowledge, attitude and acceptability of COVID-19 vaccine among residents in rural communities in Ghana: a multi-regional study
Background: The Coronavirus Infectious Disease 2019 (COVID-19) pandemic has continuously affected human life with several devastating effects. Currently, there are effective vaccines to protect people from COVID‐19 and the World Health Organization (WHO) has highlighted strategies to influence COVID-19 vaccine uptake in hard-to-reach communities in Ghana. However, prior studies on COVID-19 vaccine acceptability in Ghana are online surveys targeting the literates and those in urban areas, leaving residents in far-flung communities. We assessed knowledge, attitude and acceptability of COVID-19 vaccine among residents in rural communities in Ghana. Methods: This study was a community-based cross-sectional study and was conducted at three selected regions in Ghana (Northern, Ashanti and Western North) from May to November, 2021. This study included residents 15–81 years, living in the selected rural communities for more than 1 year. Study participants were recruited and questionnaires administered to collect data on knowledge, attitude and acceptance of the COVID-19 vaccine. Statistical analyses were performed using Statistical Package for Social Science (SPSS) version 26.0 and GraphPad Prism Version 8.0 software. Results: Of the 764 participants included in this study, more than half had inadequate knowledge (55.0%), poor attitudes (59.4%) and bad perception about COVID-19 vaccine (55.4%). The acceptability of COVID-19 vaccine in this study was 41.9%. The acceptability of COVID-19 vaccine in Ashanti, Northern and Western North regions were 32.5%, 26.2% and 29.6% respectively. In a multivariate logistic regression analysis, receiving recent or previous vaccine such as HBV vaccine [aOR = 1.57, 95% CI (1.23–3.29), p = 0.002], having good attitude towards COVID-19 vaccine [aOR = 61.47, 95% CI (29.55–127.86), p < 0.0001] and having good perception about the COVID-19 vaccine [aOR = 3.87, 95% CI (1.40–10.72), p < 0.0001] were independently associated with higher odds of accepting COVID-19 vaccine. Conclusion: More than half of residents in Ghanaian rural communities have inadequate knowledge, poor attitudes and bad perception about COVID-19 vaccine. The acceptability of COVID-19 vaccine is generally low among rural residents in Ashanti, Northern and Western North regions of Ghana. Residents living in hard-to-reach communities must be educated about the benefits of COVID-19 vaccine to achieve effective vaccination program.
- 31 January 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-11
Open AccessKnowledge, attitude and acceptability of COVID-19 vaccine among residents in rural communities in Ghana: a multi-regional study
Background: The Coronavirus Infectious Disease 2019 (COVID-19) pandemic has continuously affected human life with several devastating effects. Currently, there are effective vaccines to protect people from COVID‐19 and the World Health Organization (WHO) has highlighted strategies to influence COVID-19 vaccine uptake in hard-to-reach communities in Ghana. However, prior studies on COVID-19 vaccine acceptability in Ghana are online surveys targeting the literates and those in urban areas, leaving residents in far-flung communities. We assessed knowledge, attitude and acceptability of COVID-19 vaccine among residents in rural communities in Ghana. Methods: This study was a community-based cross-sectional study and was conducted at three selected regions in Ghana (Northern, Ashanti and Western North) from May to November, 2021. This study included residents 15–81 years, living in the selected rural communities for more than 1 year. Study participants were recruited and questionnaires administered to collect data on knowledge, attitude and acceptance of the COVID-19 vaccine. Statistical analyses were performed using Statistical Package for Social Science (SPSS) version 26.0 and GraphPad Prism Version 8.0 software. Results: Of the 764 participants included in this study, more than half had inadequate knowledge (55.0%), poor attitudes (59.4%) and bad perception about COVID-19 vaccine (55.4%). The acceptability of COVID-19 vaccine in this study was 41.9%. The acceptability of COVID-19 vaccine in Ashanti, Northern and Western North regions were 32.5%, 26.2% and 29.6% respectively. In a multivariate logistic regression analysis, receiving recent or previous vaccine such as HBV vaccine [aOR = 1.57, 95% CI (1.23–3.29), p = 0.002], having good attitude towards COVID-19 vaccine [aOR = 61.47, 95% CI (29.55–127.86), p < 0.0001] and having good perception about the COVID-19 vaccine [aOR = 3.87, 95% CI (1.40–10.72), p < 0.0001] were independently associated with higher odds of accepting COVID-19 vaccine. Conclusion: More than half of residents in Ghanaian rural communities have inadequate knowledge, poor attitudes and bad perception about COVID-19 vaccine. The acceptability of COVID-19 vaccine is generally low among rural residents in Ashanti, Northern and Western North regions of Ghana. Residents living in hard-to-reach communities must be educated about the benefits of COVID-19 vaccine to achieve effective vaccination program.